About LUMICKS
LUMICKS is a company based in Amsterdam (Netherlands) founded in 2014 by Andrea Candelli.. LUMICKS has raised $93.38 million across 10 funding rounds from investors including T. Rowe Price, European Investment Bank and Farallon Capital Management. LUMICKS offers products and services including Cell Avidity, Dynamic Single-Molecule, Avidion, C-Trap, and z-Movi. LUMICKS operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LevitasBio and Rebus Biosystems, among others.
- Headquarter Amsterdam, Netherlands
- Founders Andrea Candelli
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$93.38 M (USD)
in 10 rounds
-
Latest Funding Round
$21.87 M (USD), Debt – Venture
Oct 11, 2024
-
Investors
T. Rowe Price
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LUMICKS
LUMICKS offers a comprehensive portfolio of products and services, including Cell Avidity, Dynamic Single-Molecule, Avidion, C-Trap, and z-Movi. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Measures binding strength in cellular contexts for research applications.
Visualizes and analyzes molecular mechanisms in real-time.
Enables next-generation cell avidity analysis for studies.
Reimagines interactions through single-molecule manipulation.
Supports small-scale cell avidity studies effectively.
Offers white-glove support for cell avidity experiments.
Unlock access to complete
Unlock access to complete
Funding Insights of LUMICKS
LUMICKS has successfully raised a total of $93.38M across 10 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $21.87 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Debt – Venture — $21.9M
-
First Round
First Round
(01 Jun 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Debt – Venture - LUMICKS | Valuation |
investors |
|
| Jan, 2023 | Amount | Grant - LUMICKS | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - LUMICKS | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LUMICKS
LUMICKS has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include T. Rowe Price, European Investment Bank and Farallon Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LUMICKS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LUMICKS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lumicks Comparisons
Competitors of LUMICKS
LUMICKS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LevitasBio and Rebus Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Single-cell imaging platform developed via magnetic levitation technology.
|
|
| domain | founded_year | HQ Location |
An imaging system for single-cell gene analysis is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lumicks
Frequently Asked Questions about LUMICKS
When was LUMICKS founded?
LUMICKS was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is LUMICKS located?
LUMICKS is headquartered in Amsterdam, Netherlands.
Is LUMICKS a funded company?
LUMICKS is a funded company, having raised a total of $93.38M across 10 funding rounds to date. The company's 1st funding round was a Grant of $48.66K, raised on Jun 01, 2015.
What does LUMICKS do?
Manufacturer of optical tweezers for single-molecule analysis instruments. The product portfolio of the company includes C-Trap, an integrated system with optical tweezers, a confocal microscope, and a microfluidic system to analyze protein folding, DNA repair, DNA organization, Protein polymer, and filaments. Its product, AFS-acoustic force spectroscopy (a single molecule manipulation system), and u-Flux (an integrated microfluidic system) are used in performing experiments in a laminar flow environment.
Who are the top competitors of LUMICKS?
LUMICKS's top competitors include 10X Genomics, Mission Bio and Cellares.
What products or services does LUMICKS offer?
LUMICKS offers Cell Avidity, Dynamic Single-Molecule, Avidion, C-Trap, and 2 more products and services.
Who are LUMICKS's investors?
LUMICKS has 11 investors. Key investors include T. Rowe Price, European Investment Bank, Farallon Capital Management, European Union, and SoftBank Vision Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.